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Hepatitis B virus (HBV) and the gastric bacterium Helicobacter pylori are human pathogens of global significance. 
Estimates suggest >50% of the world population is infected with H.pylori, with 10-20% developing serious sequelae. 
An effective vaccine for HBV is available and is composed of the small HBV envelope proteins (HBsAg) which are 
able to self-assemble into virus-like particles (VLPs). However, development of a H.pylori vaccine has been hampered 
by the lack of an effective delivery system and safe adjuvants. We explored co-vaccination strategies against HBV and 
H. pylori based on modified HBsAg VLPs. This approach may address H.pylori infections, which begin primarily in 
children, and the global ambition for universal vaccination of infants against HBV. 
Methods: We inserted overlapping sequences (26-30aa) from the carboxy terminus of the H.pylori katA gene into the 
hydrophilic ‘a’ determinant region (at amino acids 127-128) of the HBsAg protein to create an expression system which 
guarantees surface orientation of inserted peptide sequences.  
Results: VLPs containing KatA epitopes were produced and were able to induce KatA specific antibodies in vaccinated 
mice. Recombinant VLPs expressing KatA epitopes were tested in a mouse challenge model, of which three constructs 
induced a significant reduction in H.pylori bacterial load, as demonstrated by culture and histological examination of 
the gastric mucosa.  
Discussion: HBsAg VLPs are highly immunogenic due to their particulate nature and repetitive sub-unit structure. We 
describe a novel delivery system which is also the first report of recombinant VLPs able to stimulate protective immune 
responses to a bacterial pathogen. 
 
 
